ArticleNational science review2024

Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target.

Hua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.